Alzheimer's Therapeutics Market Aims to Surpass US$ 7,359.7 Million by 2033 with Tailored Treatments | Future Market Insights, Inc.
26 oct. 2023 09h00 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Oct. 26, 2023 (GLOBE NEWSWIRE) -- The estimated value of the worldwide Alzheimer's in 2023 is US$ 3,052.3 million. By 2033, the market for Alzheimer's treatments is predicted to grow at...
Amydis Receives $3 Million NIH Commercialization Readiness Pilot Grant Award for Novel Amyloid Beta Retinal Tracer in Cerebral Amyloid Angiopathy
28 juin 2021 07h00 HE
|
Amydis, Inc.
SAN DIEGO, June 28, 2021 (GLOBE NEWSWIRE) -- Amydis Inc., a leading ocular tracer pharmaceutical company with a broad portfolio of diagnostic drug candidates targeting CNS biomarkers in the eye,...
Alzheimer's Diagnostics a Medical Breakthrough Attained by Global WholeHealth Partners Corp. (OTC: GWHP) as a Leading Researcher, Believes an Alzheimer's Test Will Save Lives
19 avr. 2021 06h30 HE
|
Global WholeHealth Partners Corp.
SAN CLEMENTE, CA, April 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Global WholeHealth Partners Corp. (OTC: GWHP), a multinational supplier of over 70+ FDA Approved Diagnostic Tests, attains...
Amydis Announces Successful Completion of Pre-IND Meeting with the FDA for the Development of AMDX-2011P, a First-in-Class Retinal Tracer for the Diagnosis of Amyloid Angiopathy
11 janv. 2021 07h00 HE
|
Amydis, Inc.
SAN DIEGO, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Amydis Inc., a leading ocular tracer pharmaceutical company with a broad portfolio of diagnostic drug candidates targeting CNS biomarkers in the eye,...
Amydis Diagnostics Named to San Diego Venture Group’s (SDVG) 2017 Cool Companies List
30 mai 2017 09h00 HE
|
Amydis Diagnostics, Inc.
SAN DIEGO, May 30, 2017 (GLOBE NEWSWIRE) -- Amydis Diagnostics, Inc., a preclinical stage, privately-held pharmaceutical company developing proprietary chemistry and innovative approaches to...
Amydis Diagnostics Adds Veteran Drug Development Executive and Chief Medical Officer to Management Team
17 mai 2017 09h00 HE
|
Amydis Diagnostics, Inc.
SAN DIEGO, May 17, 2017 (GLOBE NEWSWIRE) -- Amydis Diagnostics, Inc., a preclinical stage, privately-held pharmaceutical company developing proprietary chemistry and innovative approaches to...
Amydis Diagnostics Awarded NIH Grant to Further Investigate Innovative Technology for Early Detection of Alzheimer’s Disease
20 mars 2017 07h07 HE
|
Amydis Diagnostics, Inc.
SAN DIEGO, March 20, 2017 (GLOBE NEWSWIRE) -- Amydis Diagnostics, Inc., a preclinical stage, privately-held pharmaceutical company developing proprietary chemistry and innovative approaches to...
Amydis Diagnostics Awarded NIA-NIH Grant to Investigate Innovative Technology for Detection of Alzheimer's Disease
29 sept. 2015 09h00 HE
|
Amydis, Inc.
SAN DIEGO, Sept. 29, 2015 (GLOBE NEWSWIRE) -- Amydis Diagnostics, Inc., a preclinical stage, privately-held pharmaceutical company developing proprietary chemistry and innovative approaches to...